NCT01370889View on ClinicalTrials.gov

Resveratrol in Postmenopausal Women With High Body Mass Index

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Healthy, no Evidence of Disease
Interventions
DRUG

resveratrol

Given PO

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (2)

85724

University of Arizona Health Sciences Center, Tucson

85724-5024

Arizona Cancer Center - Tucson, Tucson

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT01370889 - Resveratrol in Postmenopausal Women With High Body Mass Index | Biotech Hunter | Biotech Hunter